Longitudinal single cell profiling of epitope specific memory CD4+ T cell responses to recombinant zoster vaccine
Vaccination leads to rapid expansion of antigen-specific T cells within in the first few days. However, understanding of transcriptomic changes and fates of antigen-specific T cells upon vaccination remains limited. Here, we investigate the fate of memory CD4+ T cells upon reactivation to recombinant zoster vaccine for shingles at cellular and transcriptional levels. We show that glycoprotein E-specific memory CD4+ T cells respond strongly, their frequencies remain high, and they retain markers of cell activation one year following vaccination. Memory T cells with the most dominant TCR clonotype pre-vaccination remain prevalent at year one post-vaccination. These data implicate a major role for pre-existing memory T cells in perpetuating immune repertoires upon re-encountering cognate antigens. Differential gene expression indicates that cells post-vaccination are distinct from cells at baseline, suggesting committed memory T cells display transcriptional changes upon vaccination that could alter their responses against cognate immunogens.
Authors
- David M. Koelle (ORCID: https://orcid.org/0000-0003-1255-9023)
- Emily S. Ford (ORCID: https://orcid.org/0000-0001-7358-798X)
- Scott Presnell (ORCID: https://orcid.org/0000-0001-9203-6403)
- Alex Hu (ORCID: https://orcid.org/0000-0001-6846-1776)
- Xiaomin Wen (ORCID: https://orcid.org/0000-0002-0472-9021)
- William W. Kwok (ORCID: https://orcid.org/0000-0003-4843-4599)
Institutions
- Virginia Mason Medical Center (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- AstraZeneca (United States) (US)
- Benaroya Research Institute
Publication Details
- Journal
- Nature Communications
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1038/s41467-025-57562-7
- Citations
- 2
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 1.59